On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly

On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers

(2015) Annemiek Vermeeren et al.   SLEEP

On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers

(2015) Annemiek Vermeeren et al.   SLEEP

Sensitivity and Validity of Psychometric Tests for Assessing Driving Impairment: Effects of Sleep Deprivation

(2015) Stefan Jongen et al.   PLoS One

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

(2014) David Michelson et al.   LANCET NEUROLOGY

A Physiologically Based Model of Orexinergic Stabilization of Sleep and Wake

(2014) Ben D. Fulcher et al.   PLoS One

Alcohol calibration of tests measuring skills related to car driving

(2014) Stefan Jongen et al.   PSYCHOPHARMACOLOGY

Zopiclone’s Residual Effects on Actual Driving Performance in a Standardized Test: A Pooled Analysis of Age and Sex Effects in 4 Placebo-Controlled Studies

(2013) Tim R.M. Leufkens et al.   CLINICAL THERAPEUTICS

Effects of prolonged-release melatonin and zolpidem on postural stability in older adults

(2012) Sarah Otmani et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant

(2012) W. J. Herring et al.   NEUROLOGY

Effects of Benzodiazepines, Antidepressants and Opioids on Driving

(2011) Tharaka Dassanayake et al.   DRUG SAFETY

Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype

(2011) Johannes G. Ramaekers et al.   PSYCHOPHARMACOLOGY

Next-Day Effects of Ramelteon (8 mg), Zopiclone (7.5 mg), and Placebo on Highway Driving Performance, Memory Functioning, Psychomotor Performance, and Mood in Healthy Adult Subjects

(2011) Monique A.J. Mets et al.   SLEEP

The Relationship between Benzodiazepine Use and Traffic Accidents

(2010) Beitske E. Smink et al.   CNS DRUGS

Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia

(2010) Christopher D. Cox et al.   JOURNAL OF MEDICINAL CHEMISTRY

Acute and subchronic effects of bilastine (20 and 40 mg) and hydroxyzine (50 mg) on actual driving performance in healthy volunteers

(2010) Silke Conen et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Highway Driving in the Elderly the Morning After Bedtime Use of Hypnotics

(2009) Tim R.M. Leufkens et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem

(2009) TIM R. M. LEUFKENS et al.   JOURNAL OF SLEEP RESEARCH

Tolerability, pharmacokinetics and night-time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects

(2008) Julia Boyle et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY